Browse the corpus

Cerebral aneurysms are localized dilations of cerebral arteries that most commonly occur at bifurcations within the circle of Willis. The majority are saccular in shape, with a thin or absent tunica media and fragmented internal elastic lamina, while fusiform and mycotic aneurysms are less common. Most aneurysms remain asymptomatic and are detected incidentally, though rupture can result in subarachnoid hemorrhage (SAH), presenting as a sudden, severe “thunderclap” headache with potential neurological deficits, seizures, or sudden death. This course reviews the risk factors of cerebral aneurysm, including advanced age, hypertension, smoking, alcohol use, atherosclerosis, certain genetic conditions, and family history, recommended diagnostic neuroimaging, and management strategies tailored to aneurysm characteristics and patient-specific factors. Post-rupture care, often involving monitoring and interventions to prevent complications such as vasospasm and hydrocephalus, is also discussed. This activity reviews the identification, diagnosis, and management of cerebral aneurysms. Participants will also gain an understanding of risk stratification, diagnostic approaches, surgical and endovascular interventions, and post-SAH management strategies to optimize patient outcomes, reduce morbidity and mortality, and coordinate interprofessional care effectively. This activity for healthcare professionals is designed to enhance the learner's competence in identifying cerebral aneurysms, performing the recommended evaluation, and implementing an appropriate interprofessional approach to manage this condition, thereby improving patient outcomes. Objectives: Identify common anatomic locations associated with cerebral aneurysm formation. Compare the various clinical presentations associated with cerebral aneurysms. Select evidence-based treatment strategies for cerebral aneurysms based on individualized clinical factors. Collaborate with interprofessional team members to optimize care coordination and outcomes for patients with a cerebral aneurysm. Access free multiple choice questions on this topic.

Cerebral aneurysms represent focal dilations that develop at weak points within the arterial circulation of the brain. Size varies widely, ranging from small lesions measuring less than 0.5 mm to giant aneurysms exceeding 25 mm. Most aneurysms demonstrate a saccular, or berry-shaped, morphology characterized by a thin or absent tunica media and an absent or severely fragmented internal elastic lamina. Fusiform, or circumferential, aneurysms and mycotic, or infectious, aneurysms account for a small percentage of cases, with mycotic forms considered extremely rare. Incidence in the United States approaches 13 per 100,000 population, while Japan and Finland report the highest incidence and prevalence.[1] Most cerebral aneurysms remain clinically silent and are discovered incidentally on neuroimaging. Approximately 85% occur within the anterior circulation, most commonly at arterial junctions or bifurcations along the circle of Willis (see Images. Anterior Communicating Artery Aneurysm and Ruptured Saccular Anterior Communicating Artery Aneurysm). Rupture frequently results in subarachnoid hemorrhage (SAH), a condition associated with substantial morbidity and mortality.[2][3][4]

Most cerebral aneurysms represent acquired lesions, with a higher incidence among patients who have advanced age, hypertension, smoking history, alcohol abuse, or atherosclerosis. Additional contributing factors include cocaine use, tumors, trauma, and embolic-forming infections, eg, endocarditis. A strong genetic component also influences risk, with markedly increased incidence among patients who report a significant family history of aneurysms, defined as more than 1 affected family member. Several inherited disorders demonstrate increased prevalence of cerebral aneurysms. Associated conditions include autosomal dominant polycystic kidney disease, Ehlers-Danlos syndrome, fibromuscular dysplasia, tuberous sclerosis, arteriovenous malformations, and coarctation of the aorta (see Image. Arteriovenous Malformation With Aneurysm and Intraparenchymal Bleeding).[5] Recognition of these risk factors and genetic associations supports targeted screening and early detection strategies in high-risk populations.

Worldwide prevalence of cerebral aneurysms measures approximately 3.2%, with a mean age of 50 and an overall 1:1 gender ratio. After age 50, this ratio shifts toward female predominance, approaching 2:1. Reduced circulating estrogen levels likely contribute to this shift by decreasing collagen content in vascular tissue. The annual rupture rate resulting in SAH approximates 10 per 100,000 and occurs more frequently in Finnish and Japanese populations. This increased rupture rate does not reflect a higher overall prevalence of aneurysms in these groups. Aneurysmal SAH accounts for approximately 0.4% to 0.6% of all-cause deaths. Among patients with documented rupture, mortality approaches 20%, while an additional 30% to 40% experience significant morbidity.[6]

A multifactorial process contributes to the formation of saccular aneurysms. Hemodynamic stress exerted on the internal elastic lamina leads to progressive structural breakdown over time. Vibrations generated by turbulent blood flow further promote structural fatigue within the arterial wall. Evidence also supports a role for T-cell and macrophage-mediated inflammation, which induces histologic changes in the vascular wall and facilitates aneurysmal formation and growth. This pathogenic cascade accelerates and intensifies in patients with previously described risk factors. In contrast, fusiform aneurysms most commonly arise from atherosclerotic changes, whereas mycotic aneurysms develop from septic emboli associated with infectious endocarditis.[7][8]

Clinical Features Unruptured cerebral aneurysms remain asymptomatic and cannot be detected through history and physical examination alone. Following rupture, patients commonly experience a sudden-onset severe headache, classically described as a “thunderclap headache” or “the worst headache of my life.” In 30% of cases, pain localizes to the side of the aneurysm. Brief loss of consciousness, meningismus, nausea, or vomiting may accompany the headache. Seizures occur in less than 10% of patients, while sudden death develops in 10% to 15%. Among patients with major SAH, 30% to 50% report a sudden and severe headache 6 to 20 days earlier, termed a “sentinel headache,” representing a minor hemorrhage or warning leak. Physical findings may include elevated blood pressure, dilated pupils, visual field or cranial nerve deficits, drowsiness, photophobia, motor or sensory deficits, neck stiffness, and lower back pain with neck flexion. Hunt and Hess Grading System Clinicians utilize the Hunt and Hess grading system to estimate prognosis based on initial neurologic status. This system includes 5 grades that correlate with mortality. Grade 1 involves a mild headache with slight nuchal rigidity. Grade 2 includes severe headache and stiff neck without neurologic deficit except cranial nerve palsy. Grade 3 presents with drowsiness or confusion and mild focal deficit. Grade 4 reflects stupor with moderate to severe hemiparesis. Grade 5 denotes coma with decerebrate posturing.

Most unruptured cerebral aneurysms are discovered incidentally during neuroimaging performed for unrelated reasons. High-risk individuals may undergo screening with magnetic resonance imaging (MRI), computerized tomographic (CT) angiography, or conventional angiography (see Image. Aneurysm Formation and Intraparenchymal Bleed). When rupture with suspected SAH occurs, diagnosis traditionally relies on noncontrast CT of the brain, with or without lumbar puncture. CT demonstrates high sensitivity when performed early after symptom onset; however, diagnostic accuracy declines over time. Studies report 100% sensitivity within 6 hours of onset, decreasing to 92% within 24 hours and 58% by day 5 (14 to 18). Persistent clinical suspicion despite a negative CT warrants lumbar puncture. Classic findings include elevated opening pressure and a red blood cell count that fails to diminish from tube 1 to tube 4. Xanthochromia, characterized by pink or yellow discoloration of cerebrospinal fluid due to hemoglobin breakdown products, strongly supports SAH. Visual inspection or spectrophotometry can detect xanthochromia, with a sensitivity exceeding 95% when assessed at least 12 hours after bleeding onset.[9] Following confirmation of SAH, clinicians must identify the bleeding source using CT angiography, magnetic resonance angiography, or digital subtraction angiography. Digital subtraction angiography requires catheterization of the arterial circulation, with contrast injection under fluoroscopic guidance, and serves as the gold standard for detecting aneurysmal SAH.[10][2][11]

Treatment decisions regarding cerebral aneurysms require a multifactorial assessment that includes aneurysm size, location, patient age, comorbidities, and whether rupture has occurred or the lesion was discovered incidentally. Management falls into 3 categories: surgical, endovascular, or conservative. Conservative management may suit patients of advanced age who have incidentally discovered aneurysms with low-risk features, anterior circulation location, no prior rupture, and no additional concomitant risks.[12] Surgical intervention occurs under general anesthesia in the operating room and involves placement of a small metal clip across the aneurysm neck to prevent blood flow into the sac and eliminate bleeding risk. Access requires temporary removal of a small skull segment, dural dissection, and microsurgical separation from adjacent vessels. Surgeons then secure the clip, replace the skull with thin metal plates and screws, and close the wound. Over time, the aneurysm shrinks and scars, while the clip typically remains permanently (see Image. Basilar Tip Aneurysm).[13][14] Endovascular coiling offers a less invasive option in selected cases, with potential complications that include thromboembolism and intraprocedural rupture. Clinicians insert a catheter through the femoral or radial artery, advance it to the affected vessel, and deploy a platinum coil through a microcatheter to promote thrombosis and obliterate the aneurysmal sac (see Image. Ruptured Saccular Anterior Communicating Artery Aneurysm). Rapid advances in endovascular therapy have introduced stent-assisted coiling, web-device technology, and flow-diverting stents, expanding global treatment options.[15] Rupture management includes intensive care monitoring for rebleeding, symptomatic vasospasm, hydrocephalus, seizures, and hyponatremia. Nimodipine, a calcium channel blocker, is commonly used to prevent cerebral ischemia related to vasospasm following SAH. Screening Recommendations Screening remains controversial because of cost considerations, and optimal management of small intracranial aneurysms continues to generate debate. Most experts recommend intervention once an aneurysm size reaches 7 mm or greater.[16] Postdischarge Management

Rupture management includes intensive care monitoring for rebleeding, symptomatic vasospasm, hydrocephalus, seizures, and hyponatremia. Nimodipine, a calcium channel blocker, is commonly used to prevent cerebral ischemia related to vasospasm following SAH. Screening Recommendations Screening remains controversial because of cost considerations, and optimal management of small intracranial aneurysms continues to generate debate. Most experts recommend intervention once an aneurysm size reaches 7 mm or greater.[16] Postdischarge Management Postdischarge care frequently involves physical, speech, and occupational therapy. Ongoing management includes prophylaxis against deep venous thrombosis, urinary tract infections, and seizures, along with serial imaging to confirm aneurysm obliteration.

Differential diagnoses that should be considered when evaluating a patient for a cerebral aneuysm include: Arteriovenous malformations Cavernous sinus syndromes Carotid/vertebral artery dissection Cerebral venous thrombosis Fibromuscular dysplasia Migraine and cluster headaches Moyamoya disease Pituitary apoplexy Stroke (ischemic or hemorrhagic) Vein of Galen malformation

Rupture of a cerebral aneurysm carries substantial morbidity and mortality. Nearly 25% of affected patients die within the first 24 hours, and 50% die within the subsequent 3 months.[17][18] Mortality remains high even after treatment, approaching 40%. Prognosis depends on several factors, including: Age Location of an aneurysm Degree of vasospasm Presence of hypertension and other comorbidities Neurological status on admission The extent of intraventricular hemorrhage

Complications associated with cerebral aneurysms include: Recurrent bleeding Vasospasm Seizures Syndrome of inappropriate antidiuretic hormone secretion Hydrocephalus Arrhythmias. congestive cardiac failure Gastrointestinal bleeding Deep vein thrombosis Neurogenic pulmonary edema

Specialists who are typically consulted in the management of a cerebral aneurysm include: Neurosurgeon Neurologist Interventional neuroradiologist Critical care specialist Rehabilitation consultant

Deterrence of cerebral aneurysm formation and rupture focuses on aggressive modification of known risk factors and early identification of high-risk individuals. Clinicians should counsel patients on strict blood pressure control, smoking cessation, moderation of alcohol intake, and avoidance of cocaine and other vasoactive substances. Patients with a strong family history of aneurysms or associated genetic conditions, eg, autosomal dominant polycystic kidney disease or Ehlers-Danlos syndrome, benefit from discussion regarding screening with appropriate neuroimaging. Education should also address adherence to antihypertensive therapy and routine follow-up imaging when an unruptured aneurysm has been identified. Patient education must emphasize recognition of warning symptoms, as 10% die before even reaching the emergency department, including sudden severe “thunderclap” headache, neurologic deficits, nausea, vomiting, or neck stiffness, which require immediate emergency evaluation. Individuals diagnosed with an aneurysm should understand treatment options, potential complications, and the importance of interprofessional care. Clear communication regarding postoperative care, rehabilitation needs, medication adherence, eg, nimodipine when indicated, and surveillance imaging supports improved outcomes and reduces preventable morbidity and mortality.

Cerebral aneurysms are focal dilations of intracranial arteries that arise from structural weakness in the vessel wall and are increasingly detected due to widespread use of advanced neuroimaging. Most remain asymptomatic until rupture, which can result in SAH with high morbidity and mortality. The primary clinical risk is rupture, which often occurs without warning. Early detection, systemic evaluation protocols, and timely referral to neurosurgical or interventional specialists improve outcomes, particularly before rupture.[19] Management decisions depend on aneurysm size, location, patient risk factors, and imaging findings, with treatment commonly involving surgical clipping or endovascular techniques when appropriate. Optimal care requires coordinated interprofessional collaboration. Physicians, general practitioners, and advanced practitioners assess risk, initiate diagnostic evaluation, and ensure early referral. Neurosurgeons and interventional neuroradiologists determine procedural strategies. Nurses provide education on symptom recognition and adherence to follow-up, while pharmacists counsel on blood pressure control and smoking cessation. Effective communication, shared decision-making, and coordinated care planning enhance patient safety, support individualized treatment strategies, and improve overall outcomes and team performance.